Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) Return on Equity (2021 - 2025)

Historic Return on Equity for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to 1.52%.

  • Coeptis Therapeutics Holdings' Return on Equity rose 34600.0% to 1.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.52%, marking a year-over-year increase of 34600.0%. This contributed to the annual value of 4.65% for FY2024, which is 34300.0% up from last year.
  • Per Coeptis Therapeutics Holdings' latest filing, its Return on Equity stood at 1.52% for Q3 2025, which was up 34600.0% from 1.73% recorded in Q2 2025.
  • Coeptis Therapeutics Holdings' 5-year Return on Equity high stood at 99.86% for Q1 2024, and its period low was 15.71% during Q4 2023.
  • Moreover, its 5-year median value for Return on Equity was 5.84% (2022), whereas its average is 1.45%.
  • As far as peak fluctuations go, Coeptis Therapeutics Holdings' Return on Equity soared by 1098000bps in 2024, and later crashed by -1018500bps in 2025.
  • Coeptis Therapeutics Holdings' Return on Equity (Quarter) stood at 0.09% in 2021, then tumbled by -7802bps to 6.71% in 2022, then crashed by -134bps to 15.71% in 2023, then soared by 84bps to 2.46% in 2024, then skyrocketed by 38bps to 1.52% in 2025.
  • Its last three reported values are 1.52% in Q3 2025, 1.73% for Q2 2025, and 1.99% during Q1 2025.